Moreover, targeting metabolic pathways—such as enhancing mitochondrial biogenesis via PGC-1α activation or reducing lactate-driven immunosuppression—represents an innovative avenue to restore immune competence in sepsis survivors. Here, PPARGC1A is linked to Sepsis.